Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue

AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.

Retinal diseases in patients with diabetes pose signicant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.